🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 816212302 (prev. 816212104 )
- Market Cap
- Small Cap
- IPO
- $14.00/share
- Previous Symbol
- SELB (changed 11/13/2023)
- Previous Name
- Selecta Biosciences, Inc.
Business: Cartesian Therapeutics is a clinical-stage biotechnology company pioneering RNA cell therapies for the treatment of autoimmune diseases. Cartesian’s internally manufactured portfolio is purposefully designed to be administered conveniently in an outpatient setting without preconditioning chemotherapy.
Company Contact
- CEO
- Carsten Brunn
- CFO
- Blaine Davis
- Headquarters
- 65 Grove Street Watertown, MA 02472
- Phone
- 617-923-1400
- Fax
- 617-924-3454
- Investor Relations
- Blaine Davis · 617-923-1400 · blaine@cartesiantx.com